Table 1 Half-maximal inhibitory concentration (IC50, μM) for the binding of PIB to Aβ aggregates determined using 99mTc-Ham complexes as ligands.
From: Imaging of Cerebral Amyloid Angiopathy with Bivalent 99mTc-Hydroxamamide Complexes
Compound | IC50 of PIB (μM)* | |
|---|---|---|
Aβ(1–40) | Aβ(1–42)† | |
[99mTc]SB1A | 0.38 ± 0.06 | 0.72 ± 0.10 |
[99mTc]SB1B | 0.45 ± 0.11 | 0.38 ± 0.08 |
[99mTc]SB2A | 4.59 ± 0.77 | 16.40 ± 2.47 |
[99mTc]SB2B | 3.37 ± 0.61 | 2.55 ± 0.45 |
[99mTc]BT1A | 0.24 ± 0.06 | 0.26 ± 0.02 |
[99mTc]BT1B | 0.99 ± 0.17 | 0.47 ± 0.05 |
[99mTc]BT2A | 1.58 ± 0.27 | 2.80 ± 0.32 |
[99mTc]BT2B | 4.96 ± 0.90 | 5.78 ± 0.53 |